ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS ATHE 深 沪
等待开盘 11-01 09:30:00 美东时间
4.21
-0.390
-8.48%
华盛通- 最 高4.34
- 今 开4.22
- 成交量 6.31万股
- 最 低 4.06
- 昨 收 4.60
- 总市值 6232.23万
- 52周最高 7.00
- 市盈率 静 --
- 换手率 0.43%
- 52周最低 1.001
- 委 比 0.00%
- 总股本 1480.34万
- 历史最高 51.50
- 量 比 4.10
- 振 幅 6.09%
- 历史最低 1.001
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
Double-blind trial data shows increased efficacy of ATH434 at high doses, while open-label trial results confirm similar benefits in advanced MSA. ATH434 has a potential peak sales opportunity of $2.4 billion globally. Alterity's cash balance as of September 2025 is A$54.56M. The company is engaging with the FDA to advance ATH434 toward Phase 3 trials, with an End-of-Phase 2 meeting expected in mid-2026. Positive clinical outcomes and regulatory ...
10-31 11:25
OceanPal Closes $120M PIPE To Launch SovereignAI, Positioning As Public Investment Vehicle To NEAR Protocol And AI-Driven Blockchain Infrastructure
OceanPal launches SovereignAI focused on commercializing the NEAR Protocol Deep alignment on a shared vision for universal AI sovereignty with the NEAR Foundation will facilitate the implementation of a NEAR
10-28 21:14
Hasbro Q3 Boosted By Wizards Growth, Outlook Raised
Hasbro reports Q3 beats with 8% sales growth, Wizards-driven gains, higher profits, and raised full-year revenue and EBITDA guidance outlook.
10-23 21:53
Garmin teams up with Truemed to unlock HSA/FSA funds for fitness products
Reimbursement program allows qualified U.S. customers to use pre-tax dollars on smartwatches and cycling products OLATHE, Kan., Oct. 23, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) is teaming ...
10-23 19:00
Garmin unveils D2 Air X15 and D2 Mach 2, its newest aviator smartwatches
Pilot-centric watches boast avionics connectivity and tools aviators will want on the ground and in the skies OLATHE, Kan., Oct. 22, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced ...
10-22 18:59
New Garmin OnBoard System redefines boating safety tech
Wireless Man Overboard detection and engine cutoff system integrates with Garmin chartplotters to give boaters added peace of mind OLATHE, Kan., Oct. 16, 2025 /PRNewswire/ -- Garmin (NYSE: G...
10-16 18:58
Garmin named Most Innovative Marine Company for 2025
For the third consecutive year, Garmin is honored by Soundings Trade Only for driving innovation and shaping the future of the marine industry OLATHE, Kan., Oct. 14, 2025 /PRNewswire/ -- Gar...
10-14 19:00
Danaos Corporation Announces Director Resignation
ATHENS, Greece, Oct. 13, 2025 /PRNewswire/ -- Danaos Corporation (NYSE: DAC), one of the world's largest independent owners of containerships, announced today that William Repko has resigned...
10-13 21:27
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 28.3% to $0.89 during Thursda...
10-10 05:06
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Alterity Therapeutics announced that data from its Phase 2 trial of ATH434 in Multiple System Atrophy (MSA) showed the drug slowed disease progression and stabilized orthostatic hypotension. New analyses at the MDS conference increased confidence in the trial results, with the 75 mg dose showing a strengthened efficacy signal. Advanced neuroimaging and biomarkers supported MSA diagnosis and tracked disease evolution. ATH434 demonstrated target en...
10-09 11:25
